NFH
KPTI icon

NEXT Financial Holdings’s Karyopharm Therapeutics KPTI Stock Holding History

NEXT Financial Holdings’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$0 Buy
+5
New +$554 ﹤0.01% 1649

Other funds holding KPTI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

NEXT Financial Holdings's KPTI Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in Karyopharm Therapeutics (KPTI) in Q1 2019: 5 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1649 among its holdings.

108 funds tracked by Wall St. Rank hold KPTI as of Q1 2019.

  • NEXT Financial Holdings held 5 shares of Karyopharm Therapeutics worth $0 as of Q1 2019.
  • Karyopharm Therapeutics was a new NEXT Financial Holdings position in Q1 2019.
  • Karyopharm Therapeutics made up ﹤0.01% of NEXT Financial Holdings's portfolio in Q1 2019, its #1649 holding.
  • 108 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.